Document is current
Any future updates will be listed below
-
Authors
Retnakaran, Ravi http://orcid.org/0000-0003-1989-027X
Pu, Jiajie
Ye, Chang
Emery, Alexandra
Kramer, Caroline K.
Zinman, Bernard
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02194595 at ClinicalTrials.govDocuments that mention this clinical trial
The vascular function effects of adding exenatide or meal insulin to basal insulin therapy in early type 2 diabetes
https://doi.org/10.1186/s12933-023-01781-z
-
Funding
Funding for this research was provided by:
Canadian Institutes of Health Research (MOP 136938)
Temerty Faculty of Medicine, University of Toronto
Banting and Best Diabetes Centre, University of Toronto
Heart & Stroke/Richard Lewar Centre of Excellence in Cardiovascular Research
- License Information
-
More Information
Article History
Received: 16 January 2023
Accepted: 22 February 2023
First Online: 9 March 2023
Declarations
:
: The study was approved by the Mount Sinai Hospital Research Ethics Board and registered at ClinicalTrials.Gov (NCT02194595). All participants provided written informed consent.
: RR reports grants from Boehringer Ingelheim, grants and personal fees from Novo Nordisk, personal fees from Sanofi, personal fees from Eli Lilly, outside the submitted work. CKK reports research support from Boehringer Ingelheim, outside the submitted work. All other authors declare no competing interests.
